Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Practitioners should also consider the products safety profile and regulatory status when advising patients
Targeting glutamine metabolism with a novel Na+/K+-ATPase inhibitor RX108 in hepatocellular carcinoma
While beneficial for normal growth, it poses a theoretical risk of accelerating the growth of existing or dormant cancers (for example, prostate, breast, colon) by inhibiting apoptosis (programmed cell death) and driving cell replication
Archived from the original on 11 August 2023
We do not offer refunds
The supernatants of the lysate were analyzed using assay kit F001-2 (Nanjing Jiancheng Biological Engineering Institute, Nanjing, China)
US$ 21.47
US$ 29.44
US$ 27.26
US$ 25.18
US$ 20.10
US$ 28.59
US$ 24.79
